Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study

Lung Cancer

Volumn 125, Issue , 2018, Pages 103-108

  Walter, Joan E ^a   Heuvelmans, Marjolein A ^a,b   de Bock, Geertruida H ^a   Yousaf Khan, Uraujh ^c   Groen, Harry J M ^a   van der Aalst, Carlijn M ^c   Nackaerts, Kristiaan ^d   van Ooijen, Peter M A ^a   de Koning, Harry J ^c   Vliegenthart, Rozemarijn ^a   Oudkerk, Matthijs ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Early detection of cancer; Incidence screening; Lung neoplasms; Multiple pulmonary nodules

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INFORMED CONSENT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RECEIVER OPERATING CHARACTERISTIC; AGED; BELGIUM; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; INCIDENCE; LUNG; LUNG NODULE; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; MULTIPLE PULMONARY NODULES; PATHOLOGY; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

AGED; BELGIUM; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; LUNG; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MULTIPLE PULMONARY NODULES; PROBABILITY; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85053768718     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2018.05.007     Document Type: Article

References (27)

1. Bach, P.B., Mirkin, J.N., Oliver, T.K., Azzoli, C.G., Berry, D.A., Brawley, O.W., Byers, T., Colditz, G.A., Gould, M.K., Jett, J.R., Sabichi, A.L., Smith-Bindman, R., Wood, D.E., Qaseem, A., Detterbeck, F.C., Benefits and harms of CT screening for lung cancer. J. Am. Med. Assoc., 307, 2012, 2418, 10.1001/jama.2012.5521.
2. Smith, R.A., Andrews, K.S., Brooks, D., Fedewa, S.A., Manassaram-Baptiste, D., Saslow, D., Brawley, O.W., Wender, R.C., Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J. Clin. 67 (2017), 100–121, 10.3322/caac.21392.
3. De Koning, H.J., Meza, R., Plevritis, S.K., Ten Haaf, K., Munshi, V.N., Jeon, J., Erdogan, S.A., Kong, C.Y., Han, S.S., Van Rosmalen, J., Choi, S.E., Pinsky, P.F., De Gonzalez, A.B., Berg, C.D., Black, W.C., Tammemagi, M.C., Hazelton, W.D., Feuer, E.J., McMahon, P.M., Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive services task force. Ann. Intern. Med. 160 (2014), 311–320, 10.7326/M13-2316.
4. Aberle, D.R., Adams, A.M., Berg, C.D., Black, W.C., Clapp, J.D., Fagerstrom, R.M., Gareen, I.F., Gatsonis, C., Marcus, P.M., Sicks, J.D., Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365 (2011), 395–409, 10.1056/NEJMoa1102873.
5. Wilson, D.O., Weissfeld, J.L., Fuhrman, C.R., Fisher, S.N., Balogh, P., Landreneau, R.J., Luketich, J.D., Siegfried, J.M., The Pittsburgh lung screening study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am. J. Respir. Crit. Care Med. 178 (2008), 956–961, 10.1164/rccm.200802-336OC.
6. Swensen, S.J., Jett, J.R., Hartman, T.E., Midthun, D.E., Mandrekar, S.J., Hillman, S.L., Sykes, A.-M., Aughenbaugh, G.L., Bungum, A.O., Allen, K.L., CT screening for lung cancer: five-year prospective experience. Radiology 235 (2005), 259–265, 10.1148/radiol.2351041662.
7. van Klaveren, R.J., Oudkerk, M., Prokop, M., Scholten, E.T., Nackaerts, K., Vernhout, R., van Iersel, C.A., van den Bergh, K.A.M., van ’t Westeinde, S., van der Aalst, C., Thunnissen, E., Xu, D.M., Wang, Y., Zhao, Y., Gietema, H.A., de Hoop, B.-J., Groen, H.J.M., de Bock, G.H., van Ooijen, P., Weenink, C., Verschakelen, J., Lammers, J.-W.J., Timens, W., Willebrand, D., Vink, A., Mali, W., de Koning, H.J., Management of lung nodules detected by volume CT scanning. N. Engl. J. Med. 361 (2009), 2221–2229, 10.1056/NEJMoa0906085.
8. Field, J.K., Duffy, S.W., Baldwin, D.R., Whynes, D.K., Devaraj, A., Brain, K.E., Eisen, T., Gosney, J., Green, B.A., Holemans, J.A., Kavanagh, T., Kerr, K.M., Ledson, M., Lifford, K.J., McRonald, F.E., Nair, A., Page, R.D., Parmar, M.K.B., Rassl, D.M., Rintoul, R.C., Screaton, N.J., Wald, N.J., Weller, D., Williamson, P.R., Yadegarfar, G., Hansell, D.M., UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 71 (2016), 161–170, 10.1136/thoraxjnl-2015-207140.
9. Walter, J.E., Heuvelmans, M.A., Oudkerk, M., Small pulmonary nodules in baseline and incidence screening rounds of low-dose CT lung cancer screening. Transl. Lung Cancer Res. 6 (2017), 42–51, 10.21037/tlcr.2016.11.05.
10. American College of Radiology, LungRADS™ Version 1.0 Assessment Categories Release Date: April 28, 2014 (2014). https://www.acr.org/-/media/ACR/Files/RADS/Lung-RADS/LungRADS_AssessmentCategories.pdf. (Accessed 1 September 2016).
11. Callister, M.E.J., Baldwin, D.R., Akram, A.R., Barnard, S., Cane, P., Draffan, J., Franks, K., Gleeson, F., Graham, R., Malhotra, P., Prokop, M., Rodger, K., British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 70 (2015), 1–54, 10.1136/thoraxjnl-2015-207168.
12. McWilliams, A., Tammemagi, M.C., Mayo, J.R., Roberts, H., Liu, G., Soghrati, K., Yasufuku, K., Martel, S., Laberge, F., Gingras, M., Atkar-Khattra, S., Berg, C.D., Evans, K., Finley, R., Yee, J., English, J., Nasute, P., Goffin, J., Puksa, S., Stewart, L., Tsai, S., Johnston, M.R., Manos, D., Nicholas, G., Goss, G.D., Seely, J.M., Amjadi, K., Tremblay, A., Burrowes, P., MacEachern, P., Bhatia, R., Tsao, M.-S., Lam, S., Probability of cancer in pulmonary nodules detected on first screening CT. N. Engl. J. Med. 369 (2013), 910–919, 10.1056/NEJMoa1214726.
13. MacMahon, H., Naidich, D.P., Goo, J.M., Lee, K.S., Leung, A.N.C., Mayo, J.R., Mehta, A.C., Ohno, Y., Powell, C.A., Prokop, M., Rubin, G.D., Schaefer-Prokop, C.M., Travis, W.D., Van Schil, P.E., Bankier, A.A., Guidelines for management of incidental pulmonary nodules detected on CT images: from the fleischner society. Radiology, 2017, 161659, 10.1148/radiol.2017161659.
14. Raji, O.Y., Duffy, S.W., Agbaje, O.F., Baker, S.G., Christiani, D.C., Cassidy, A., Field, J.K., Predictive accuracy of the liverpool lung project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann. Intern. Med. 157 (2012), 242–250, 10.7326/0003-4819-157-4-201208210-00004.
15. Heuvelmans, M.A., Walter, J.E., Peters, R.B., de Bock, G.H., Yousaf-Khan, U., van der Aalst, C.M., Groen, H.J.M., Nackaerts, K., van Ooijen, P.M., de Koning, H.J., Oudkerk, M., Vliegenthart, R., Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: the NELSON study. Lung Cancer 113 (2017), 45–50, 10.1016/j.lungcan.2017.08.023.
16. Henschke, C.I., Naidich, D.P., Yankelevitz, D.F., McGuinness, G., McCauley, D.I., Smith, J.P., Libby, D., Pasmantier, M., Vazquez, M., Koizumi, J., Flieder, D., Altorki, N., Miettinen, O.S., Early lung cancer action project: initial findings on repeat screening. Cancer 92 (2001), 153–159, 10.1002/1097-0142(20010701)92:1<153:AID-CNCR1303>3.0.CO;2-S.
17. International Early Lung Cancer Action Program Investigators, Henschke, C.I., Yankelevitz, D.F., Libby, D.M., Pasmantier, M.W., Smith, J.P., Miettinen, O.S., Survival of patients with stage I lung cancer detected on CT screening. N. Engl. J. Med. 355 (2006), 1763–1771, 10.1056/NEJMoa060476.
18. Swensen, S.J., Jett, J.R., Sloan, J.A., Midthun, D.E., Hartman, T.E., Sykes, A.M., Aughenbaugh, G.L., Zink, F.E., Hillman, S.L., Noetzel, G.R., Marks, R.S., Clayton, A.C., Pairolero, P.C., Screening for lung cancer with low-dose spiral computed tomography. Am. J. Respir. Crit. Care Med. 165 (2002), 508–513, 10.1164/ajrccm.165.4.2107006.
19. Walter, J.E., Heuvelmans, M.A., de Jong, P.A., Vliegenthart, R., van Ooijen, P.M.A., Peters, R.B., ten Haaf, K., Yousaf-Khan, U., van der Aalst, C.M., de Bock, G.H., Mali, W., Groen, H.J.M., de Koning, H.J., Oudkerk, M., Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol. 17 (2016), 907–916, 10.1016/S1470-2045(16)30069-9.
20. Starnes, S.L., Reed, M.F., Meyer, C.A., Shipley, R.T., Jazieh, A.R., Pina, E.M., Redmond, K., Huffman, L.C., Pandalai, P.K., Howington, J.A., Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis?. J. Thorac. Cardiovasc. Surg. 141 (2011), 688–693, 10.1016/j.jtcvs.2010.08.045.
21. Yousaf-Khan, U., van der Aalst, C., de Jong, P.A., Heuvelmans, M., Scholten, E., Walter, J., Nackaerts, K., Groen, H., Vliegenthart, R., ten Haaf, K., Oudkerk, M., de Koning, H., Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax 72 (2017), 819–824, 10.1136/thoraxjnl-2016-209892.
22. Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C.P., Bastarrika, G., Sverzellati, N., Mascalchi, M., Delorme, S., Baldwin, D.R., Callister, M.E., Becker, N., Heuvelmans, M.A., Rzyman, W., Infante, M.V., Pastorino, U., Pedersen, J.H., Paci, E., Duffy, S.W., De Koning, H., Field, J.K., European position statement on lung cancer screening. Lancet Oncol. 18 (2017), e754–e766, 10.1016/S1470-2045(17)30861-6.
23. Xu, D.M., Gietema, H., de Koning, H., Vernhout, R., Nackaerts, K., Prokop, M., Weenink, C., Lammers, J.W., Groen, H., Oudkerk, M., van Klaveren, R., Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 54 (2006), 177–184, 10.1016/j.lungcan.2006.08.006.
24. Van Iersel, C.A., De Koning, H.J., Draisma, G., Mali, W.P.T.M., Scholten, E.T., Nackaerts, K., Prokop, M., Habbema, J.D.F., Oudkerk, M., Van Klaveren, R.J., Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int. J. Cancer 120 (2007), 868–874, 10.1002/ijc.22134.
25. Yousaf-Khan, U., van der Aalst, C., de Jong, P.A., Heuvelmans, M., Scholten, E., Lammers, J.-W., van Ooijen, P., Nackaerts, K., Weenink, C., Groen, H., Vliegenthart, R., Ten Haaf, K., Oudkerk, M., de Koning, H., Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Thorax 72 (2016), 1–9, 10.1136/thoraxjnl-2016-208655.
26. Heuvelmans, M.A., Oudkerk, M., de Jong, P.A., Mali, W.P., Groen, H.J.M., Vliegenthart, R., The impact of radiologists’ expertise on screen results decisions in a CT lung cancer screening trial. Eur. Radiol. 25 (2015), 792–799, 10.1007/s00330-014-3467-4.
27. Horeweg, N., van Rosmalen, J., Heuvelmans, M.A., van der Aalst, C.M., Vliegenthart, R., Scholten, E.T., ten Haaf, K., Nackaerts, K., Lammers, J.W.J., Weenink, C., Groen, H.J., van Ooijen, P., de Jong, P.A., de Bock, G.H., Mali, W., de Koning, H.J., Oudkerk, M., Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol. 15 (2014), 1332–1341, 10.1016/S1470-2045(14)70389-4.